Xyntha: Services and support

Look beyond treatment - to a world of support

Trial prescription program, insurance programs, scholarships, patient assistance, community resources. The more you look at Xyntha® Antihemophilic Factor (Recombinant), Plasma/Albumin-Free, the more it has to offer.

Trial prescription program

Get a 1-month supply up to 20,000 IU at no cost to you — talk to your doctor to see if you are eligible.

Community resources

Get hemophilia news, inspiring stories, tips on healthy living, and updates on Pfizer products and services.

Payment support*

Save on co-pay, deductible, and coinsurance costs.
*Terms and Conditions apply.

Access and Affordability

Learn how RSVP can help you gain access to the medicines you need.

Click here to learn more and to see if you qualify.

Scholarship program

Pfizer awards up to $50,000 in scholarships to students in the hemophilia community.

To learn more click here.

Ambassador program

Share the knowledge and experiences you've gained in managing hemophilia through educational and promotional projects sponsored by Pfizer.

To find out more or to get a booklet and DVD, call our toll-free telephone number at 1-877-360-4366.

Contact Pfizer

Get information and answers to questions about Pfizer resources, products, and services.

To learn more visit www.Pfizer.com.

Quick Poll

What do you like the most about the R2 Kit?

Low 4-mL diluent

2000-IU vial

It comes in a travel-ready pack

It's convenient

Your Results

What's different about XYNTHA?

Learn what XYNTHA has that other factor VIII products don't.

Convenient reconstitution for your lifestyle

Click here for the one-of-a-kind R2 Kit.

See what life on XYNTHA is like

Click here to hear from people with hemophilia A.

What Is XYNTHA?

Xyntha is indicated for the control and prevention of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency or classic hemophilia) and for surgical prophylaxis in patients with hemophilia A.

XYNTHA does not contain von Willebrand factor and, therefore, is not indicated in von Willebrand's disease.

Important Safety Information for XYNTHA

Allergic reactions are possible with XYNTHA. Signs of an allergic reaction may include hives, rash with itching, chest tightness, difficulty breathing, faintness, or fast heartbeat. XYNTHA contains trace amounts of hamster protein. You may develop an allergic reaction to these proteins. Tell your doctor if you have had an allergic reaction to hamster protein.
Call your doctor right away if bleeding is not controlled after using your factor VIII replacement therapy; this may be a sign of an inhibitor. Inhibitors have been observed in patients receiving factor VIII products, including XYNTHA.
The most common adverse reaction in study 1 (safety and efficacy study) is headache (24% of subjects) and in study 2 (surgery study) is fever (41% of subjects). Other common side effects of XYNTHA include nausea, vomiting, diarrhea, or weakness.
XYNTHA is an injectable medicine administered by intravenous (IV) infusion.

Please see full Prescribing Information.

Need help accessing Pfizer medicines?
Pfizer's RSVP program may be able to help.
Call 1-888-327-RSVP (7787) or visit www.HemophiliaVillage.com/RSVP

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Join Hemophilia Village today and get community news and resources sent to your mailbox or in-box.

Marketed by Pfizer Inc.
June 2011

The health information contained herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All decisions about patient care must be made with a health care provider, considering the unique characteristics of the patient.

The product information provided in this site is intended for residents of the United States. The products discussed herein may have different product labeling in different countries.

RUS288549-01